id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-E-1946-0006,FDA,FDA-2019-E-1946,Determination of Regulatory Review Period for Purposes of Patent Extension; LOKELMA,Notice,Determinations,2023-02-08T05:00:00Z,2023,2,2023-02-08T05:00:00Z,2023-04-11T03:59:59Z,2023-02-08T19:53:31Z,2023-02667,0,0,090000648563e93e
FDA-2019-E-1946-0005,FDA,FDA-2019-E-1946,Letter from FDA CDER TO U.S. Patent and Trademark Office,Other,Letter(s),2023-02-02T05:00:00Z,2023,2,2023-02-02T05:00:00Z,,2023-02-02T17:29:41Z,,0,0,090000648562d1b4